Clinical Trials Browser

Phase 2 × Leukemia, Promyelocytic, Acute × lintuzumab × Clear all

NCT00002609 2013-06-24

Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00016159 2013-01-16

Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute